Epidemiological surveillance cultures in antimicrobial-resistant bacteria causing nosocomial infection;Cultivos de vigilancia epidemiológica de bacterias resistentes a los antimicrobianos de interés nosocomial

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue 4, 2008, Pages 220-229

  Cano, María Eliecer ^a   Domínguez, Ma Ángeles ^b   Ezpeleta, Carmen ^c   Padilla, Belén ^d   Ramírez De Arellano, Encarnación ^e   Martínez Martínez, Luis ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

A. baumannii; Extended spectrum lactamases; Glycopeptide resistant enterococcus; Methicillin resistant s. Aureus; Multiresistance; Nosocomial infection; P. aeruginosa; Surveillance cultures

Indexed keywords

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; ENTEROCOCCUS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; REVIEW;

EID: 42149178463     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/s0213-005x(08)72694-6     Document Type: Review

References (38)

1. Rodríguez-Baño J, Pascual A. Microorganismos multirresistentes, ¿adquisición nosocomial o comunitaria? Enferm Infecc Microbiol Clin. 2004;22:505-6.
2. Cuevas O, Cercenado E, Vindel A, Guinea J, Sánchez-Conde M, Sánchez-Somolinos M, et al. Evolution of the antimicrobial resistance of Staphylococcus spp. in Spain: five nationwide prevalence studies, 1986 to 2002. Antimicrob Agents Chemother. 2004;48:4240-5.
3. Domínguez-Luzón MA, Rodríguez-Baño J. Infecciones por estafilococos. En: Auxina Ruiz V, Moreno Guillén S, editores. Tratado SEIMC de Enfermedades Infecciosas y Microbiología Clínica. Madrid: Editorial Médica Panamericana; 2006. p. 263-82.
4. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA Guideline for Preventing Nosocomial Transmission of Multi-drug-Resistant Strains of Staphylococcus aureus and Enterococcus. Infect.Control Hosp Epidemiol 2003;24:362-86.
5. Perry JD, Davies A, Butterworth LA, Hopley AL, Nicholson A, Gould FK. Development and evaluation of a chromogenic agar medium for methicillin- resistant Staphylococcus aureus. J Clin Microbiol. 2004;42:4519-23.
6. Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M, et al. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol. 2004;42:1875-84.
7. Warren DK, Liao RS, Merz LR, Eveland M, Dunne M Jr. Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-time PCR assay. J Clin Microbiol. 2004;42:5578-81.
8. Cavassini M, Wenger A, Jaton K, Blanc DS, Bille J. Evaluation of MRSA-Screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol. 1999;37:1591-4.
9. Cetinkaya Y, Falk P, Mayhall GC. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13:686-707.
10. Francia MV. Enterococcus resistentes a glucopéptidos en Europa: un problema hospitalario creciente. Enferm Infecc Microbiol Clin. 2005;23:457-9.
11. Landman D, Quale JM, Oydna E, Willey B, Ditore V, Zaman M, et al. Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. J Clin Microbiol. 1996;34:751-2.
12. Palladino S, Kay ID, Flexman JP, Boehm I, Costa AM, Lambert EJ, et al. Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay. J Clin Microbiol. 2003;41:2483-6.
13. Paule SM, Trick WE, Tenover FC, Lankford M, Cunningham S, Stosor V, et al. Comparison of PCR assay to culture for surveillance detection of vancomycin-resistant enterococci. J Clin Microbiol. 2003;41:4805-7.
14. Sloan LM, Uhl JR, Vetter EA, Schleck CD, Harmsen WS, Manahan J, et al. Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs. J Clin Microbiol. 2004;42:2636-43.
15. Ambler RP, Coulson AF, Frere J, Ghuysen JM, Joris B, Fosrman M, et al. A standard numbering scheme for the class A beta-lactamases. Biochem J. 1991;276:269-70.
16. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 1995;39:1211-33.
17. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a Clinical update. Clin Microbiol Rev. 2005;18:657-86.
18. Hernández-Bello JR, Pascual A, Cantón R, Martínez-Martínez L y Grupo de Estudio de Infección Hospitalaria (GEIH). E. coli y K. pneumoniae productoras de beta-lactamasas de espectro extendido en hospitales españoles (Proyecto GEIH-BLEE 2000). Enf Infecc Microbiol Clin. 2003;21:77-82.
19. Hernández JR, Martínez-Martínez L, Cantón R, Coque TM, Pascual A, Spanish Group for Nosocomial Infections (GEIH). Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother. 2005;49:2122-5.
20. Rodríguez-Baño J, Navarro MD, Romero L, Martínez- Martínez L, Muniaín MA, Perea EJ, et al. Epidemiology and clinical features of infections caused by Extended-Spectrum Beta-lactamase-producing E. coli in nonhospitalized patiens. J Clin Microbiol. 2004;42:1084-94.
21. Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of fecal carriage of extended spectrum β-lactamase producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol. 2004;42:4769-75.
22. Glupczynski Y, Berhin C, Bauraing C, Bogaerts P. Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum beta-lactamase-producing enterobacteriaceae. J Clin Microbiol. 2007;45:501-5.
23. National Committee for Clinical Laboratory Standards. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement (M100-S16). National Committee for Clinical Laboratory Standards, Wayne. Pa.
24. Rice LB, Carias LL, Hujer AM, Bonafede M, Hutton R, Hoyen C, et al. High-level expression of chromosomally encode SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2000;44:362-7.
25. Leverstein-van Hall MA, Fluit AC, Paauw A, Box AT, Brisse S, Verhoef J. Evaluation of the Etest ESBL and the BD Phoenix, Vitek 1 and Vitek 2 automated instruments for detection of extended spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J Clin Microbiol. 2002;40:3703-11.
26. Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microb Rev. 1996;9:148-65.
27. Fernández-Cuenca F, Martínez-Martínez L, Conejo MC, Ayala JA, Perea EJ, Pascual A. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother. 2003;51:565-74.
28. Fernández-Cuenca F, Pascual A, Ribera A, Vila J, Bou G, Cisneros JM, et al. Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000). Enferm Infecc Microbiol Clin. 2004;22:267-71.
29. Rodríguez-Baño J, Cisneros JM, Fernández-Cuenca F, Ribera A, Vila J, Pascual A, et al. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol. 2004;25:819-24.
30. Villegas MV, Hartstein AI. Acinetobacter outbreaks 1977-2000. Infect Control Hosp Epidemiol. 2003;24:284-96.
31. Cisneros JM, Rodríguez-Baño J, Fernández-Cuenca F, Ribera A, Vila J, Pascual A, et al. Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect. 2005;11:874-9.
32. Bouza E, García-Garrote F, Cercenado E, Marín M, Díaz MS, Sánchez Romero I, et al. Pseudomonas aeruginosa: a multicenter study in 136 hospitals in Spain. Rev Esp Quimioter. 2003;16:41-52.
33. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother. 2001;47:247-50.
34. Prats G, Miró E, Mirelis B, Poirel L, Bellais S, Nordmann P. First isolation of a carbapenem-hydrolyzing β-lactamase in Pseudomonas aeruginosa in Spain. Antimicrob Agents Chemother. 2002;46:932-3.
35. Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem-susceptible metallo-β-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol. 2006;44:3139-44.
36. Mendes RE, Kiyota KA, Monteiro J, Castanheira M, Andrade SS, Gales AC, et al. Rapid Detection and Identification of Metallo-β-Lactamase-Encoding Genes by Multiplex Real-Time PCR Assay and Melt Curve Analysis. J Clin Microbiol. 2007;45:544-47.
37. Carmeli Y, Torillet N, Elliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother. 1999;43:1379-82.
38. Defez C, Fabbro-Peray P, Bouziges N, Gouby A, Mahamat A, Daurès JP, et al. Risk factors for multidrug resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect. 2004;57:209-16.